The relationship of intranasal steroids to intraocular pressure

Current Allergy and Asthma Reports

Volumn 9, Issue 4, 2009, Pages 311-315

  Bergmann, Joseph ^a   Witmer, Matthew T ^a   Slonim, Charles B ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTISONE; SCLEROPROTEIN; STEROID;

ALLERGIC CONJUNCTIVITIS; AQUEOUS HUMOR OUTFLOW; CONNECTIVE TISSUE DISEASE; DIABETES MELLITUS; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG MEGADOSE; DRUG WITHDRAWAL; FIRST PASS EFFECT; GENE ACTIVITY; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; MYOPIA; OPEN ANGLE GLAUCOMA; PREVALENCE; RECOMMENDED DRUG DOSE; REVIEW; RISK FACTOR; SIDE EFFECT; TRABECULAR MESHWORK; TREATMENT DURATION; TREATMENT RESPONSE;

ADMINISTRATION, INTRANASAL; ADRENAL CORTEX HORMONES; CONJUNCTIVITIS, ALLERGIC; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; RHINITIS, ALLERGIC, PERENNIAL;

EID: 68349122514     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-009-0044-z     Document Type: Review

References (22)

1. Bui CM, Chen H, Shyr Y, et al.: Discontinuing nasal steroids might lower intraocular pressure in glaucoma. J Allergy Clin Immunol 2005, 116: 1042-1047.
2. Willsie SK: Improved strategies and new treatment options for allergic rhinitis. J Am Osteopath Assoc 2002, 102(6 Suppl 2): S7-S14.
3. Dupclay L Jr, Doyle J: Assessment of intranasal corticosteroid use in allergic rhinitis: Benefits, costs, and patient preferences. Am J Manag Care 2002, 8(Suppl 13): S335-S340.
4. USP Drug Information for the Health Care Professional, Advice for the Patient, Approved Drug Products, and Legal Requirements, edn 12. Rockville, MD: United States Pharmacopeial Convention, Inc.; 1992:56-62.
5. Schenkel EJ, Skoner DP, Bronsky EA, et al.: Absence of growth retardation in children with perennial allergic rhinitis after one year of treatment with mometasone furoate aqueous nasal spray. Pediatrics 2000, 105: E22.
6. Benninger MS, Ahmad N, Marple BF: The safety of intranasal steroids. Otolaryngol Head Neck Surg 2003, 129: 739-750.
7. Glaucoma Research Foundation: Glaucoma facts. Available at http://www.glaucoma.org/learn/glaucoma_facts.php. Accessed January 2009.
8. Tripathi RC, Parapuram SK, Tripathi BJ, et al.: Corticosteroids and glaucoma risk. Drugs Aging 1999, 15: 439-450.
9. Gordon DM, McLean JM, Koteen H: Present status of corticotropin; ACTH, cortisone, and hydrocortisone in ophthalmology. Br J Ophthalmol 1953, 37: 85-98.
10. Armaly MF: The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 1966, 75: 32-35.
11. Garbe E, LeLorier J, Boivin JF, et al.: Inhaled and nasal glucocorticoids and the risks of ocular hypertension or open-angle glaucoma. JAMA 1997, 277: 722-727.
12. Opatowsky I, Feldman RM, Gross R, et al.: Intraocular pressure elevation associated with inhalation and nasal corticosteroids. Ophthalmology 1995, 102: 177-179.
13. Mitchell P, Cumming RG, Mackey DA: Inhaled corticosteroids, family history, and risk of glaucoma. Ophthalmology 1999, 106: 2301-2306.
14. Spiliotopoulos C, Mastronikolis NS, Petropoulos IK, et al.: The effect of nasal steroid administration on intraocular pressure. Ear Nose Throat J 2007, 86: 394-395.
15. Ozturk F, Yuceturk AV, Kurt E, et al.: Evaluation of intraocular pressure and cataract formation following the long-term use of nasal corticosteroids. Ear Nose Throat J 1998, 77: 846-848; 850-851.
16. Becker B: The genetic problem of chronic simple glaucoma. Ann Ophthalmol 1971, 3: 351-354.
17. Kanski JJ: Clinical Ophthalmology: A Systematic Approach, edn 6. Philadelphia: Butterworth Heineman Elsevier; 2007.
18. Clark AF, Wilson K, McCartney MD, et al.: Glucocorticoid-induced formation of cross-linked actin networks in cultured human trabecular meshwork cells. Invest Ophthalmol Vis Sci 1994, 35: 281.
19. Cave A, Arlett P, Lee E: InhaFed and nasal corticosteroids: factors affecting the risks of systemic advers effects. Pharmacol Ther 1999, 83: 153-179.
20. Jones R 3rd, Rhee DJ: Corticosteroid-induced ocular hypertension and glaucoma: A brief review and update of the literature. Curr Opin Ophthalmol 2006, 17: 163-167.
21. Stokes J, Walker BR, Campbell JC, et al.: Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003, 44: 5163-5167.
22. Carnahan MC, Goldstein DA: Ocular complications of topical, peri-ocular, and systemic corticosteroids. Curr Opin Ophthalmol 2000, 11: 478-483.